Navigation Links
Karolinska Development AB Announces Publication of Year End Report for 2009
Date:3/15/2010

STOCKHOLM, March 15, 2010 /PRNewswire/ -- Karolinska Development AB announces publication of its Year End Report 2009 on the company's website.

    Key events during the year:

    Group

    October - December 2009

    - Revenue increased by 8.3 % to 6.9 (6.4) MSEK.
    - Operating income amounted to -22.1 (-249.0) MSEK.
    - Profit after tax amounted to -19.4 (-246.4) MSEK.
    - Income per share before dilution amounted to -0.71 (-10.15) SEK.
    - Investments in portfolio companies during the period amounted to 27.1
      (65.0) MSEK.
    - Cashflow during the period 322.3 (55.5) MSEK.
    - Value of the total portfolio according to the International Private
      Equity and Venture Capital Valuation Board (IPEV Valuation Board)
      guidelines has at the balance sheet date been estimated at 1,512.3 MSEK
      compared to 1,321.8 MSEK as of December 31, 2008.

    January - December 2009

    - Revenue increased by 30.5 % to 30.3 (23.2) MSEK.
    - Operating income amounted to -13.5 (-70.5) MSEK.
    - Profit after tax amounted to -2.6 (-57.7) MSEK.
    - Income per share before dilution amounted to -0.10 (-2.34) SEK.
    - Investments in portfolio companies during the period amounted to 172.4
      (148.6) MSEK.
    - Cash flow during the period amounted to 204.8 (180.3) MSEK.

    Parent company

    January - December 2009

    - Revenue increased by 116.1 % to 6.7 (3.1) MSEK.
    - Operating loss amounted to -101.1 (-61.5) MSEK.

The entire report is available on http://www.karolinskadevelopment.com under Investors> Reports.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies. The portfolio includes a total of 19 potential first in class products. http://www.karolinskadevelopment.com

    Conny Bogentoft
    CEO Karolinska Development
    Tel: +46(0)706-68-61-43,
    e-mail: conny.bogentoft@karolinskadevelopment.com
    Karolinska Development AB (publ)
    Org.nr 556707-5048


SOURCE Karolinska Development AB

Back to top
'/>"/>
SOURCE Karolinska Development AB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
2. 3 new honorary doctors at Karolinska Institutet
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. Karolinska Development Invests in EvoStem Finland Oy
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio
8. Michael J. Fox Receives Honorary Doctorate From Karolinska Institute
9. Michael J. Fox to be made honorary doctor at Karolinska Institutet
10. Isolation of a new gene family essential for early development
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
Breaking Medicine Technology: